• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

UNC0064-12

CAS No. 1430089-64-7

UNC0064-12 ( UNC0064-12, UNC-0064-12, UNC 0064-12, UNC006412 )

产品货号. M11817 CAS No. 1430089-64-7

2,4-Pyrimidinediamine with linker is a patent compound in WO2013055780A1.

纯度: >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥2001 有现货
10MG ¥2989 有现货
25MG ¥5038 有现货
50MG ¥7169 有现货
100MG ¥9639 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    UNC0064-12
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    2,4-Pyrimidinediamine with linker is a patent compound in WO2013055780A1.
  • 产品描述
    2,4-Pyrimidinediamine with linker is a patent compound in WO2013055780A1, Page 71; multikinase inhibitor and has a -NH2 terminal linker for further synthesis.
  • 同义词
    UNC0064-12, UNC-0064-12, UNC 0064-12, UNC006412
  • 通路
    Angiogenesis
  • 靶点
    VEGFR
  • 受体
    VEGFR
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    1430089-64-7
  • 分子量
    364.45
  • 分子式
    C19H24N8
  • 纯度
    >98%(HPLC)
  • 溶解度
    DMSO: 10 mM
  • SMILES
    NCCCNC1=CC=C(NC2=NC=CC(NC3=NNC(C4CC4)=C3)=N2)C=C1
  • 化学全称
    N2-[4-[(3-Aminopropyl)amino]phenyl]-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.MULTIPLEXED KINASE INHIBITOR BEADS AND USES THEREOF. Patent Application WO/2013/055780 Kind Code: A1
产品手册
关联产品
  • Bevacizumab

    Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.

  • Lenvatinib mesylate

    Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities.

  • Vatalanib

    A potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.